In focus
Latest feed
Johnson & Johnson: A Premium Price for a Premium Company – But Is It Too Rich Right Now?
Another Chapter Unfolds: Jury Finds Johnson & Johnson Liable in Baby Powder Cancer Case
The Shifting Tides for Kraft Heinz: A Look at Its Credit Downgrade
Unlocking Faster Drug Production: FDA Launches 'Precheck' for New Pharma Plants
